Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  H. Lundbeck A/S    LUN   DK0010287234

Delayed Quote. Delayed  - 07/22 04:59:56 pm
270.5 DKK   +0.04%
07/07 IDALOPIRDINE GR : Designation provides the opportunity for more freq..
06/23 H LUNDBECK A/S : U.S. FDA Approves Changes to the SABRIL® (vigabatri..
06/02 H LUNDBECK A/S : Transactions with shares and linked securities in H..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo H. Lundbeck A/S
Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases

H. Lundbeck A/S is a pharmaceutical company, which is engaged in the business of research, development, production and sale of pharmaceuticals for the treatment of brain diseases.

The company was founded by Hans Lundbeck on August 14, and is headquartered in Valby, Denmark.

Number of employees : 5 257 persons.
Sales per Businesses
20142015Delta
DKK (in Million)%DKK (in Million)%
Cipralex4,64734.5%---
Other Pharmaceuticals1,98514.7%---
Xenazine1,69512.6%---
Azilect1,49711.1%---
Ebixa1,0587.9%---
Onfi923.006.9%---
Sabril716.005.3%---
Other Revenue547.004.1%---
Treanda212.001.6%---
Brintellix188.001.4%---
Pharmaceuticals--14,594100.9%-
Sales per Regions
20142015Delta
DKK (in Million)%DKK (in Million)%
Rest of Europe4,99137.1%3,86926.7% -22.48%
International4,14430.8%3,82726.5% -7.65%
United States3,75827.9%6,35343.9% +69.05%
Other Revenue547.004.1%518.003.6% -5.3%
Denmark28.000.2%27.000.2% -3.57%
Managers
NameAgeSinceTitle
Kåre Schultz552015President & Chief Executive Officer
Sven Håkan Björklund MD, PhD592011Chairman
Anders Götzsche492007CFO & Executive VP-Information Technology
Anders Gersel Pedersen MD, PhD652000Executive Vice President-Research & Development
Jørn Møller Mayntzhusen, MBA502002Director & Senior Manager-Supply Optimisation
Mona Elisabeth Elster541994Director
Lars Søren Rasmussen572013Independent Director
Terrie Curran472014Independent Director
Henrik Sindal Jensen, PhD472004Director
Lene Skole-Sørensen572015Deputy Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 197,515,325 60,032,630 30.4% 130,777 0.1% 30.4%
Shareholders
NameEquities%
Lundbeck Foundation 137,351,918 69.5%
Wellington Management Co. LLP 9,866,717 5.00%
OppenheimerFunds, Inc. 3,990,143 2.02%
TIAA-CREF Investment Management LLC 3,204,860 1.62%
Teachers Advisors, Inc. 2,796,417 1.42%
Norges Bank Investment Management 1,963,697 0.99%
Templeton Global Advisors Ltd. 1,816,677 0.92%
Nordea Investment Management AB (Denmark) 1,738,195 0.88%
Oddo Meriten Asset Management SA 1,342,615 0.68%
Janus Capital Management LLC 1,189,662 0.60%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
H. LUNDBECK A/S18.10%7 885
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.53%219 526
ROCHE HOLDING LTD.-9.55%218 832
MERCK & CO., INC.11.36%162 815
BRISTOL-MYERS SQUIBB C..10.02%126 333
NOVO NORDISK A/S-5.44%111 381
SANOFI-3.03%108 205
GLAXOSMITHKLINE PLC20.87%105 959
ALLERGAN PLC-20.33%98 486
ELI LILLY AND CO-3.17%90 116
BAYER AG-20.73%83 560
ASTRAZENECA PLC-2.01%77 183
ABBOTT LABORATORIES-3.87%63 423
SHIRE PLC4.60%58 447
TEVA PHARMACEUTICAL IN..-16.35%50 478
ASTELLAS PHARMA INC-3.61%33 577
TAKEDA PHARMACEUTICAL ..-25.70%33 169
MYLAN NV-13.83%23 685
CHUGAI PHARMACEUTICAL ..-6.47%20 549
Sector Pharmaceuticals - NEC
H. Lundbeck A/S : Connections
LEGO A/S
Danish Society of Internal Medicine
Fonden Lundbeck International Neuroscience Foundation
Danish Society of Medical Oncology
Lundbeck Pharma A/S
Rosborg Møbler A/S
American Chamber of Commerce Executives, Inc.
Confederation of Danish Industry
Tryg Forsikring A/S
Atos Medical AB
Lundbeckfond Invest A/S
Coloplast Ejendomme A/S
Lundbeck Cognitive Therapeutics A/S
European Society for Medical Oncology
The British Chambers of Commerce
American Society of Clinical Oncology
Coloplast Danmark A/S
International Association for the Study of Lung Cancer
Company contact information
9 Ottiliavej
DK 2500 Valby, Copenhagen
Denmark

Phone : +45 36 30 13 11
Fax : +45 36 30 19 40
Internet : http://www.lundbeck.com
Markets and indexes
- NASDAQ OMX nordic Kopenhagen
- Main Market Large
- OMXC 20 /
Stock Exchange Codes
- ISIN Code :  DK0010287234
- Bloomberg Code :  LUN:DC
- Reuters Code :  LUN.CO
- Datastream Code :  DK:LUND
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem